| Krishna J Mohan M D Inc | |
|
171 W Cottage Dr Covina CA 91723-2010 | |
| (626) 331-0175 | |
| (626) 967-3849 |
| Full Name | Krishna J Mohan M D Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 171 W Cottage Dr, Covina, California |
| Authorized Official Name and Position | Krishna Jatavallabhula Mohan (MEDICAL DIRECTOR) |
| Authorized Official Contact | 6263310175 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Krishna J Mohan M D Inc 171 W Cottage Street Covina CA 91723 Ph: (626) 331-0175 | Krishna J Mohan M D Inc 171 W Cottage Dr Covina CA 91723-2010 Ph: (626) 331-0175 |
| NPI Number | 1780781997 |
|---|---|
| Provider Enumeration Date | 09/20/2006 |
| Last Update Date | 08/18/2022 |
| Medicare PECOS PAC ID | 9830184217 |
|---|---|
| Medicare Enrollment ID | O20040415001085 |
News Archive
Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780781997 | NPI | - | NPPES |
| 00A341750 | Other | CA | MEDI-CAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | (* (Not Available)) | Primary |
| Provider Name | Krishna J Mohan |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1477645786 PECOS PAC ID: 3072424035 Enrollment ID: I20040416000395 |
News Archive
Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.
› Verified 7 days ago
| Provider Name | Sheri Aihuong Pham |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639261951 PECOS PAC ID: 5294717682 Enrollment ID: I20040601000788 |
News Archive
Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.
› Verified 7 days ago
| Provider Name | Farhad Rezvani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982796207 PECOS PAC ID: 9739239187 Enrollment ID: I20090608000004 |
News Archive
Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.
› Verified 7 days ago
News Archive
Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.
› Verified 7 days ago
Hani Hashem, Md, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 546 W Badillo St Ste D, Covina, CA 91722 Phone: 626-331-2222 Fax: 626-331-2233 | |
Rodolfo E Magsino Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 21304 E Arrow Hwy, Covina, CA 91724 Phone: 626-915-2055 Fax: 626-915-2098 | |
Dagher Md Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 376 W Badillo St, Covina, CA 91723 Phone: 626-332-1175 Fax: 626-966-8746 | |
Thomas T. Ha, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 530 W Badillo St, Suite E, Covina, CA 91722 Phone: 626-858-5370 | |
Covina Surgery Center, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 246 W College St Ste 200, Covina, CA 91723 Phone: 323-982-0004 | |
East San Gabriel Valley Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1359 N Grand Ave, Covina, CA 91724 Phone: 626-430-2900 Fax: 626-331-0035 | |
Healthy Family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 218 W Badillo St, Covina, CA 91723 Phone: 626-332-6234 Fax: 626-331-1264 |